No case of bad quality generic medicines in India: Mandaviya

Image
Press Trust of India New Delhi
Last Updated : Jul 24 2018 | 2:20 PM IST

Not a single case of poor quality of generic drugs have been reported from the nearly 4,000 centres across India selling such medicines, Union Minister Mansukh Mandaviya said in Lok Sabha today.

Responding to supplementaries, the Minister of State for Chemicals and Fertilizers also said that one in six generic medicines the world over is manufactured in India.

He said generic medicines have so far captured six per cent of the market in the pharmaceutical sector.

The minister said samples are regularly collected from Jan Aushadhi Kendras and so far there has not been a single report of the centres selling sub-standard generic drugs.

As on July 17, 3,851 such centre were selling generic medicines which are far cheaper than the branded medicines.

Explaining the difference between generic and branded medicines, Mandaviya said the cost of packaged drinking water depends on the brand under which it is sold.

He said the salt in the medicines was the same but much depends on the brand and packaging.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 24 2018 | 2:20 PM IST

Next Story